Cesca Therapeutics Inc. (NASDAQ:KOOL), formerly known as ThermoGenesis Corp., announced that Dr. Mahendra Rao has been appointed to the Company’s board of directors effective April 1, 2014. His appointment brings the Company’s number of directors to six. Cesca Therapeutics Inc. (NASDAQ:KOOL) stock opened at $1.90 in last session, and closed at $1.90, while the day range of Cesca Therapeutics Inc. (NASDAQ:KOOL) stock is $1.62 – $1.92. The stock showed a positive weekly performance of -13.24%.
Acura Pharmaceuticals (NASDAQ:ACUR) had its price objective raised by MLV & Co. from $2.00 to $2.25 in a research report released on Wednesday morning, American Banking News reports. Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) stock opened at $1.70 in last session, and closed at $1.81 by gaining 7.74%. The 52 week range of $1.35 – $3.78. Company’s market capitalization is $85.90 million.
On February 27, 2014, the Compensation Committee of the Board of Directors of ARCA biopharma, Inc. (NASDAQ:ABIO), approved cash bonuses (the “Bonuses”) for each of the executive officers of the Company in the amounts set forth below, payable on or around March 7, 2014. Arca Biopharma Inc. (NASDAQ:ABIO) stock increased 11.34% and finished the last session at $2.16. The EPS of the stock remained -1.49. Company’s market capitalization is $23.40 million.
BG Medicine, Inc. (NASDAQ:BGMD) announcement by La Jolla Pharmaceutical Company (LJPC) on March 10, 2014 of positive top-line results of its randomized, placebo-controlled Phase 2 trial of the galectin-3 inhibitor compound GCS-100 in chronic kidney disease. BG Medicine, Inc. (NASDAQ:BGMD) stock opened the session at $1.38, and closed the session at $1.34. The 52 week range of the BG Medicine, Inc. (NASDAQ:BGMD) stock remained $0.55 – $2.24 and the day range was $1.31 – $1.55.